المؤلفون: Sean D. Sullivan, Nick Freemantle, Rishab A. Gupta, Jasmanda Wu, Charlie J. Nicholls, Jukka Westerbacka, Timothy S. Bailey

المصدر: Endocrinology, Diabetes & Metabolism, Vol 5, Iss 1, Pp n/a-n/a (2022)

مصطلحات موضوعية: high risk, hypoglycaemia, Insulin glargine 300 units/mL, real‐world study, type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2398-9238Test

الوصول الحر: https://doaj.org/article/3e4e2d0713d14cf48c6252433ddab72eTest

المؤلفون: Landgraf, Wolfgang, Bigot, Gregory, Hess, Sibylle, Asplund, Olof, Groop, Leif, Ahlqvist, Emma, Käräjämäki, Annemari, Owens, David R., Frier, Brian M., Bolli, Geremia B.

المساهمون: Centre of Excellence in Complex Disease Genetics, HUS Abdominal Center, Institute for Molecular Medicine Finland, Leif Groop Research Group, Clinicum, University of Helsinki

مصطلحات موضوعية: 3121 General medicine, internal medicine and other clinical medicine, C-peptide, Cluster, Randomised clinical trial, Real-world studies, Type 2 diabetes, INSULIN GLUCOSE CONTROL, NAIVE PEOPLE, TO-TARGET TRIAL, C -peptide, NPH INSULIN, ORAL-AGENTS, THERAPY, BASAL INSULIN, PLUS METFORMIN, HYPOGLYCEMIA, GLARGINE 100 UNITS/ML, Real -world studies

وصف الملف: application/pdf

العلاقة: This work is dedicated to the memory of Prof. Jürgen Sandow, a passionate pharmacologist and endocrinologist. The authors would like to thank Tiinamaija Tuomi, University of Helsinki, and Mathieu Coudert, Keni Lee, and Jukka Westerbacka, all of Sanofi, for input and/or critical review of this manuscript. The DIREVA Study has been supported by the Vaasa Hospital District, State Research funding via the Turku University Hospital, Vaasa Central Hospital, Jakobstadsnejdens Heart Foundation, the Medical Foundation of Vaasa, and the Finnish Medical Foundation. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The underlying diabetes RCTs were funded by Sanofi. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The underlying diabetes RCTs were funded by Sanofi. This work is dedicated to the memory of Prof. Jürgen Sandow, a passionate pharmacologist and endocrinologist. The authors would like to thank Tiinamaija Tuomi, University of Helsinki, and Mathieu Coudert, Keni Lee, and Jukka Westerbacka, all of Sanofi, for input and/or critical review of this manuscript. The DIREVA Study has been supported by the Vaasa Hospital District, State Research funding via the Turku University Hospital, Vaasa Central Hospital, Jakobstadsnejdens Heart Foundation, the Medical Foundation of Vaasa, and the Finnish Medical Foundation.; Landgraf , W , Bigot , G , Hess , S , Asplund , O , Groop , L , Ahlqvist , E , Käräjämäki , A , Owens , D R , Frier , B M & Bolli , G B 2022 , ' Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials : Post hoc cluster assignment analysis of over 12,000 study participants ' , Diabetes Research and Clinical Practice , vol. 190 , 110012 . https://doi.org/10.1016/j.diabres.2022.110012Test; 85134646102; 5c882532-f28f-47ef-a1e3-c25e9304203c; http://hdl.handle.net/10138/346686Test; 000834575200002

الإتاحة: http://hdl.handle.net/10138/346686Test

المؤلفون: Meyers, Eline, Coen, Anja, De Sutter, An, Padalko, Elizaveta, Callens, Steven, Vandekerckhove, Linos, Witkowski, Wojciech, Heytens, Stefan, Cools, Piet

المصدر: JOURNAL OF CLINICAL VIROLOGY ; ISSN: 1386-6532 ; ISSN: 1873-5967

مصطلحات موضوعية: Medicine and Health Sciences, Infectious Diseases, Virology, Vaccination, Serosurveillance, Enzyme-linked immunosorbent assay (ELISA), Dried blood spots (DBS), International Units/mL, Serology, SARS-CoV-2

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://biblio.ugent.be/publication/8763787Test; http://hdl.handle.net/1854/LU-8763787Test; http://dx.doi.org/10.1016/j.jcv.2022.105270Test; https://biblio.ugent.be/publication/8763787/file/8772945Test

الإتاحة: https://doi.org/10.1016/j.jcv.2022.105270Test
https://biblio.ugent.be/publication/8763787Test
http://hdl.handle.net/1854/LU-8763787Test
https://biblio.ugent.be/publication/8763787/file/8772945Test

المؤلفون: Sullivan, Sean D, Freemantle, Nick, Gupta, Rishab A, Wu, Jasmanda, Nicholls, Charlie J, Westerbacka, Jukka, Bailey, Timothy S

المصدر: Endocrinology, Diabetes & Metabolism , 5 (1) , Article e00306. (2022)

مصطلحات موضوعية: High risk, hypoglycaemia, Insulin glargine 300 units/mL, real-world study, type 2 diabetes

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10174065/1/EDM2-5-e00306.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10174065Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10174065/1/EDM2-5-e00306.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10174065Test/

المؤلفون: Rajadnya, Vikram Anant, More, Diya Amol

المساهمون: There is no funding source whatsoever for any part of this original research project.

المصدر: International Journal of Basic & Clinical Pharmacology; Vol 10, No 7 (2021): July 2021; 830-833 ; 2279-0780 ; 2319-2003

مصطلحات موضوعية: Insulin glargine vials 100 units/ml, Cost, Annual cost

وصف الملف: application/pdf

العلاقة: https://www.ijbcp.com/index.php/ijbcp/article/view/4725/3236Test; https://www.ijbcp.com/index.php/ijbcp/article/downloadSuppFile/4725/3946Test; https://www.ijbcp.com/index.php/ijbcp/article/downloadSuppFile/4725/3947Test; https://www.ijbcp.com/index.php/ijbcp/article/view/4725Test

الإتاحة: https://doi.org/10.18203/2319-2003.ijbcp20212381Test
https://www.ijbcp.com/index.php/ijbcp/article/view/4725Test

المؤلفون: Freemantle, N., Bonadonna, Riccardo C, Gourdy, P., Mauricio Puente, Dídac, Mueller-Wieland, D., Bigot, Gregory, Ciocca, A., Mauquoi, C., Rollot, M., Bonnemaire, Mireille, Universitat Autònoma de Barcelona

مصطلحات موضوعية: Clinical practice, Europe, Insulin glargine 300 units/mL, Pooled analysis, Type 2diabetes mellitus

وصف الملف: application/pdf

العلاقة: BMJ open; Vol. 10 Núm. 4 (28 2020), p. 201903365; https://ddd.uab.cat/record/283708Test; urn:10.1136/bmjopen-2019-033659; urn:oai:ddd.uab.cat:283708; urn:scopus_id:85084169702; urn:articleid:20446055v10n4p201903365; urn:pmid:32350009; urn:pmc-uid:7213840; urn:pmcid:PMC7213840; urn:oai:pubmedcentral.nih.gov:7213840

الإتاحة: https://ddd.uab.cat/record/283708Test

المؤلفون: Ritzel, Robert, Roussel, Ronan, Giaccari, Andrea, Vora, Jiten, Brulle-Wohlhueter, Claire, Yki-Järvinen, Hannele

المساهمون: Department of Medicine, Clinicum, University of Helsinki, HUS Internal Medicine and Rehabilitation

مصطلحات موضوعية: glycaemic control, hypoglycaemia, insulin analogues, meta-analysis, phase III study, type 2 diabetes, ORAL ANTIHYPERGLYCEMIC DRUGS, INCLUDING 6-MONTH EXTENSION, GLUCOSE CONTROL, BASAL INSULIN, TRIAL, UNITS/ML, ASSOCIATION, RESISTANCE, ADHERENCE, ADULTS, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This study was sponsored by Sanofi; Ritzel , R , Roussel , R , Giaccari , A , Vora , J , Brulle-Wohlhueter , C & Yki-Järvinen , H 2018 , ' Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL : 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes ' , Diabetes, obesity and metabolism , vol. 20 , no. 3 , pp. 541-548 . https://doi.org/10.1111/dom.13105Test; 85042091142; e8a82eac-158f-4b5b-9018-3499e5c6a218; http://hdl.handle.net/10138/234041Test; 000425013600007

الإتاحة: http://hdl.handle.net/10138/234041Test

المؤلفون: Harris, Stewart B., Parente, Erika B., Karalliedde, Janaka

المساهمون: CAMM - Research Program for Clinical and Molecular Metabolism, University of Helsinki, Nefrologian yksikkö

مصطلحات موضوعية: OUTCOMES, Insulin glargine 300 U, PATHOPHYSIOLOGY, nutritional and metabolic diseases, Type 2 diabetes, SEVERE HYPOGLYCEMIA, mL, Basal insulin analogues, PEOPLE, GLYCEMIC CONTROL, 3121 General medicine, internal medicine and other clinical medicine, Glycaemic control, TRIAL, Hypoglycaemia, BASAL INSULIN, ELDERLY-PATIENTS, GLUCOSE CONTROL, 100 UNITS/ML

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1593::1d2de0f9d19ad81e279da67feee45f61Test
http://hdl.handle.net/10138/343688Test

المؤلفون: Ritzel, R., Roussel, R., Bolli, G. B., Vinet, L., Brulle-Wohlhueter, C., Glezer, S., Yki-Järvinen, Hannele

المساهمون: Clinicum, Hannele Yki-Järvinen Research Group, Department of Medicine

مصطلحات موضوعية: basal insulin, insulin glargine, insulin therapy, GLUCOSE CONTROL, RISK, UNITS/ML, BASAL, General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This study was sponsored by Sanofi. The authors thank the study participants, trial staff, and investigators for their participation. The authors would also like to thank Cassandra Pessina (Sanofi) for critical review of the manuscript, and for assistance with management of the manuscript development. Editorial and writing assistance was provided by Rachel Wright of Fishawack Communications Ltd and was funded by Sanofi.; Ritzel , R , Roussel , R , Bolli , G B , Vinet , L , Brulle-Wohlhueter , C , Glezer , S & Yki-Järvinen , H 2015 , ' Patient-level meta-analysis of the EDITION 1, 2 and 3 studies : glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes ' , Diabetes, obesity and metabolism , vol. 17 , no. 9 , pp. 859-867 . https://doi.org/10.1111/dom.12485Test; http://hdl.handle.net/10138/208847Test; f35cc1b6-34ad-46c2-9fca-79888f9583a3; 84939572199; 000360215900006

الإتاحة: http://hdl.handle.net/10138/208847Test

المؤلفون: Riddle, M. C., Yki-Järvinen, Hannele, Bolli, G. B., Ziemen, M., Muehlen-Bartmer, I., Cissokho, S., Home, P. D.

المساهمون: Clinicum, Hannele Yki-Järvinen Research Group, Department of Medicine

مصطلحات موضوعية: basal insulin, glycaemic control, insulin glargine, meal-time insulin, GLUCOSE CONTROL, ORAL-AGENTS, METABOLISM, UNITS/ML, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: This study was funded by Sanofi. The authors thank the study participants, trial staff, and investigators for their participation. A full list of the principal investigators at the clinical sites has previously been reported [6]. The authors would also like to thank Cassandra Pessina (Sanofi) for critical review of the manuscript, and for assistance with management of the manuscript development. Editorial assistance was funded by Sanofi and provided by Fiona Woodward of Fishawack Communications.; Riddle , M C , Yki-Järvinen , H , Bolli , G B , Ziemen , M , Muehlen-Bartmer , I , Cissokho , S & Home , P D 2015 , ' One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin : the EDITION 1 12-month randomized trial, including 6-month extension ' , Diabetes, obesity and metabolism , vol. 17 , no. 9 , pp. 835-842 . https://doi.org/10.1111/dom.12472Test; 84939575735; 5d698d62-f64c-47fb-9d9a-93649ac6a9fa; http://hdl.handle.net/10138/209599Test; 000360215900003

الإتاحة: http://hdl.handle.net/10138/209599Test